Table 1. Patient Characteristics in the Etomidate-Midazolam Group and Propofol-Ketamine Group a,b.
| Patient Characteristics | EM Group c | PK Group c | P Value |
|---|---|---|---|
| Gender (F/M), n (%) | 17/33 (34/66) | 15/35 (30/70) | 0.668 |
| Age, y | 57.16 ± 5.6 | 57.36 ± 5.5 | 0.858 |
| ASA class, n (%) | 0.534 | ||
| II | 33 (66) | 30 (60) | |
| III | 17 (34) | 20 (40) | |
| EF, % | 35.8 ± 4.6 | 35.3 ± 4.8 | 0.602 |
| Weight, kg | 71.28 ± 11.2 | 72.06 ± 8.7 | 0.700 |
| Time required for intubation, s | 22.50 ± 4.3 | 23.40 ± 5.6 | 0.370 |
a Abbreviations: ASA, American Society of Anesthesiologists; EF, ejection fraction; F, female; M, male; Group EM, Etomidate-Midazolam group; and Group PK, Propofol-Ketamine group.
b Values are presented as Mean ± SD or No. (%).
c n = 50.